TY - JOUR
T1 - Use of bronchoscopy in percutaneous dilational tracheostomy
AU - Gadkaree, Shekhar K.
AU - Schwartz, Diane
AU - Gerold, Kevin
AU - Kim, Young
N1 - Publisher Copyright:
Copyright 2016 American Medical Association. All rights reserved.
PY - 2016/2
Y1 - 2016/2
N2 - IMPORTANCE A modified percutaneous dilational tracheostomy (PDT) is a relatively new alternativemethod of performing PDTs in which tissues overlying the trachea are dissected, but needle entry is still performed blindly. Many centers use bronchoscopy-assisted PDT, but the necessity of bronchoscope assistance for modified PDTs has not been examined. Discontinuing bronchoscopy for this procedure could potentially decrease cost and increase efficiency with similar outcomes compared with bronchoscopy-assisted PDT. OBJECTIVE To evaluate the necessity of bronchoscopy in placement of PDT. DESIGN, SETTING, AND PARTICIPANTS A single-center, retrospective cohort study of 149 patients who underwent PDT, with or without bronchoscope assistance, was conducted between May 1, 2007, and February 1, 2015, in a tertiary care facility. Data analysis was performed from April 15, 2015, to May 1, 2015. INTERVENTIONS Modified PDT with or without bronchoscopy. MAIN OUTCOMES AND MEASURES The primary outcomes of interestwere postprocedural complications and length of stay during the hospitalization at which the tracheostomy was placed. RESULTS Of the 149 patients who underwent modified PDT during the study period and met the inclusion criteria, 107 were in the no-bronchoscope cohort (66 [61.7%] were men; mean [SD] age, 56.0 [18.7] years) and 42 were in the bronchoscope-assisted cohort (26 [61.9%] were men; mean [SD] age, 58.0 [15.7] years). Complications with PDT were significantly associated with use of a bronchoscope (odds ratio, 6.7; 95%CI, 1.3-43.4; P = .04). The rate of complications was 1.9%in the no-bronchoscope cohort and 11.9%in the bronchoscopeassisted cohort (P = .05). The mean (SD) length of hospital stay was not significantly different between the 2 groups (51.4 [49.4] days in the no-bronchoscope cohort vs 46.9 [28.6] days in the bronchoscope-assisted cohort; P = .58). CONCLUSIONS AND RELEVANCE Percutaneous dilational tracheostomy can be performed with similarly low complication rates with or without the use of bronchoscopy. Discontinuing the use of bronchoscopy in these procedures appears to be a safe, cost-effective alternative with reassuring outcomes and low complication rates.
AB - IMPORTANCE A modified percutaneous dilational tracheostomy (PDT) is a relatively new alternativemethod of performing PDTs in which tissues overlying the trachea are dissected, but needle entry is still performed blindly. Many centers use bronchoscopy-assisted PDT, but the necessity of bronchoscope assistance for modified PDTs has not been examined. Discontinuing bronchoscopy for this procedure could potentially decrease cost and increase efficiency with similar outcomes compared with bronchoscopy-assisted PDT. OBJECTIVE To evaluate the necessity of bronchoscopy in placement of PDT. DESIGN, SETTING, AND PARTICIPANTS A single-center, retrospective cohort study of 149 patients who underwent PDT, with or without bronchoscope assistance, was conducted between May 1, 2007, and February 1, 2015, in a tertiary care facility. Data analysis was performed from April 15, 2015, to May 1, 2015. INTERVENTIONS Modified PDT with or without bronchoscopy. MAIN OUTCOMES AND MEASURES The primary outcomes of interestwere postprocedural complications and length of stay during the hospitalization at which the tracheostomy was placed. RESULTS Of the 149 patients who underwent modified PDT during the study period and met the inclusion criteria, 107 were in the no-bronchoscope cohort (66 [61.7%] were men; mean [SD] age, 56.0 [18.7] years) and 42 were in the bronchoscope-assisted cohort (26 [61.9%] were men; mean [SD] age, 58.0 [15.7] years). Complications with PDT were significantly associated with use of a bronchoscope (odds ratio, 6.7; 95%CI, 1.3-43.4; P = .04). The rate of complications was 1.9%in the no-bronchoscope cohort and 11.9%in the bronchoscopeassisted cohort (P = .05). The mean (SD) length of hospital stay was not significantly different between the 2 groups (51.4 [49.4] days in the no-bronchoscope cohort vs 46.9 [28.6] days in the bronchoscope-assisted cohort; P = .58). CONCLUSIONS AND RELEVANCE Percutaneous dilational tracheostomy can be performed with similarly low complication rates with or without the use of bronchoscopy. Discontinuing the use of bronchoscopy in these procedures appears to be a safe, cost-effective alternative with reassuring outcomes and low complication rates.
UR - http://www.scopus.com/inward/record.url?scp=84958956119&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958956119&partnerID=8YFLogxK
U2 - 10.1001/jamaoto.2015.3123
DO - 10.1001/jamaoto.2015.3123
M3 - Article
C2 - 26720516
AN - SCOPUS:84958956119
SN - 2168-6181
VL - 142
SP - 143
EP - 149
JO - JAMA Otolaryngology - Head and Neck Surgery
JF - JAMA Otolaryngology - Head and Neck Surgery
IS - 2
ER -